These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 310678)

  • 1. A controlled study of ANA+ RF- arthritis.
    Linn JE; Hardin JG; Halla JT
    Arthritis Rheum; 1978; 21(6):645-51. PubMed ID: 310678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies].
    Punzi L; di Maggio C; Mazzi A; Presacco D; Ruffatti A; Pellegrini A; Todesco S
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):563-6. PubMed ID: 3499656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
    Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
    Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
    Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB
    J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.
    Vasiliauskiene L; Wiik A; Høier-Madsen M
    Ann Rheum Dis; 2001 May; 60(5):459-66. PubMed ID: 11302867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-organ specific & organ specific antibodies in rheumatoid arthritis.
    Datta A; Deodhar SD; Datta U; Sehgal S
    Indian J Med Res; 1990 Aug; 92():228-32. PubMed ID: 2228066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
    Scott-Morgan L; Lloyd RS
    Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage.
    Meyer O; Combe B; Elias A; Benali K; Clot J; Sany J; Eliaou JF
    Ann Rheum Dis; 1997 Nov; 56(11):682-5. PubMed ID: 9462172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease.
    Caspi D; Elkayam O; Eisinger M; Vardinon N; Yaron M; Burke M
    Rheumatol Int; 2001 Feb; 20(2):43-7. PubMed ID: 11269531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
    Ordeig J; Guardia J
    J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rheumatoid factor, antinuclear antibodies and plasma reagin on the serologic assay for Lyme disease.
    Lovece S; Stern R; Kagen LJ
    J Rheumatol; 1991 Dec; 18(12):1813-8. PubMed ID: 1795317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic structure of the population with rheumatoid arthritis in north east England: a genetic approach to define different subtypes.
    Papiha SS; Lanchbury JS; Pal B
    Ann Rheum Dis; 1986 Nov; 45(11):881-91. PubMed ID: 3491586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of immuno-serological laboratory data].
    Kasukawa R; Tojo J; Kuwana T; Obara K
    Rinsho Byori; 1996 Dec; 44(12):1157-63. PubMed ID: 8990934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospect for an additional laboratory criterion for rheumatoid arthritis.
    von Essen R; Kurki P; Isomäki H; Okubo S; Kautiainen H; Aho K
    Scand J Rheumatol; 1993; 22(6):267-72. PubMed ID: 7505480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiographic and clinico-serologic correlations in rheumatoid arthritis].
    Baldelli S; Corvetta A; Ghirelli PA
    Minerva Med; 1984 Feb; 75(6):269-71. PubMed ID: 6200804
    [No Abstract]   [Full Text] [Related]  

  • 18. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
    Janssens X; Veys EM; Verbruggen G; Declercq L
    J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
    Matsos MP; Pope JE; Spencer-Green G
    Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.